Ignite Creation Date:
2024-05-06 @ 6:01 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05511948
Status:
COMPLETED
Last Update Posted:
2023-10-25
First Post:
2022-08-20
Brief Title:
Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs Vehicle vs Hydroquinone on Skin Pigmentation and Lentigos
Sponsor:
DermBiont Inc
Organization:
DermBiont Inc
Study Overview
Official Title:
A Randomized Observer-Blinded Vehicle-Controlled Study on the Safety and Efficacy of Twice Daily Application of Ruboxistaurin DBI-102 Gel VsVehicle Gel Vs Hydroquinone Cream on Sun-Exposed and Sun-Protected Skin of Adults
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized observer-blinded vehicle-controlled multi-dose trial that examines the effect of twice daily application of 08 DBI-102 Gel 4 Hydroquinone cream and Vehicle Gel for 12 weeks in adults with Fitzpatrick Skin Types IV-V and a colorimeter L measurement between 578 and 461
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None